NCT00170898View on ClinicalTrials.gov

Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

419

Participants

Timeline

Start Date

November 30, 2004

Conditions

Musculoskeletal Pain

Interventions

DRUG

Lumiracoxib

Trial Locations (1)

Unknown

For site information contact, Novartis Pharmaceuticals UK Limited, Frimley

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY